Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
申请人:BEECHAM GROUP PLC
公开号:EP0000816A1
公开(公告)日:1979-02-21
A class of substituted amino pyridine derivatives are of value in the treatment of diabetes. Some of the compounds also possess hypolipidaemic activity.
The compounds are represented by the formula (I):
wherein R3 is hydrogen, alkyl or an acidic function;
R2 is hydrogen or alkyl;
R4 and R' are hydrogen, alkyl or halogen;
Z is hydrogen, phenyl, alkyl or aralkyl;
Alk is alkylene and x is 0 or 1;
R1 is optionally substituted phenyl or naphthyl.
Most of the compounds of formula (I) are novel.
NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF
申请人:MITSUBISHI TANABE PHARMA CORPORATION
公开号:US20170044133A1
公开(公告)日:2017-02-16
Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The present invention relates to a compound represented by the following formula (I):
[wherein each symbol is as described in the DESCRIPTION], which has a superior autotaxin inhibitory action and is useful as a prophylactic or therapeutic drug for diseases involving ATX.
US9783522B2
申请人:——
公开号:US9783522B2
公开(公告)日:2017-10-10
Remarkably Efficient Iridium Catalysts for Directed C(sp<sup>2</sup>)–H and C(sp<sup>3</sup>)–H Borylation of Diverse Classes of Substrates
aliphatic substrates for selective C(sp3)–H bond borylations. Heterocyclic molecules are selectively borylated using the inherently elevated reactivity of the C–H bonds. A number of late-stage C–H functionalization have been described using the same catalysts. Furthermore, we show that one of the catalysts could be used even in open air for the C(sp2)–H and C(sp3)–Hborylations enabling the method more general